In: Biomedicine & Pharmacotherapy
Subjects: SÍNDROME CORONARIANA AGUDA INFARTO DO MIOCÁRDIO PROGNÓSTICO
ABNT
LEOCÁDIO, Paola Caroline Lacerda; MENTA, Penélope Lacrísio dos Reis; DIAS, Melissa Tainan Silva; et al. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis. Biomedicine & Pharmacotherapy, Paris, Editions Scientifiques et Medicales Elsevier, v. 109, p. 1411-1416, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/29790?show=full > DOI: 10.1016/j.biopha.2018.10.087.APA
Leocádio, P. C. L., Menta, P. L. dos R., Dias, M. T. S., Fraga, J. R., Goulart, A. C., Santos, I. de S., et al. (2019). Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis. Biomedicine & Pharmacotherapy, 109, 1411-1416. doi:10.1016/j.biopha.2018.10.087NLM
Leocádio PCL, Menta PL dos R, Dias MTS, Fraga JR, Goulart AC, Santos I de S, Lotufo PA, Benseñor IM, Alvarez-Leite JI. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 109 1411-1416.Available from: http://observatorio.fm.usp.br/handle/OPI/29790?show=fullVancouver
Leocádio PCL, Menta PL dos R, Dias MTS, Fraga JR, Goulart AC, Santos I de S, Lotufo PA, Benseñor IM, Alvarez-Leite JI. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 109 1411-1416.Available from: http://observatorio.fm.usp.br/handle/OPI/29790?show=full